Capstone Therapeutics Announces Results of Special Shareholder Meeting, and a License Transfer/Royalty Agreement and Exit from the Pharmaceutical Development Business
ALSIP, IL / ACCESSWIRE / February 18, 2021 / Capstone Therapeutics (OTCQB:CAPS) (“the Company”) On…